Development of an <i>In Vitro</i> Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release.

Mol Ther Methods Clin Dev · 2020 · PMC7139127 · PMID 32280725

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

These showed a highly significant correlation, with the cell culture-based assay demonstrating less variation than the in vivo test.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.